GEF vs HSAI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GEF presents a conflicting profile characterized by a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health, despite trading below its intrinsic value of $71.39. While the PEG ratio (0.77) and Forward P/E (14.24) suggest potential value, the company has missed earnings estimates in four consecutive quarters with a significant average surprise of -47.31%. The high dividend payout ratio of 89.26% combined with bearish insider activity and negative revenue growth creates a precarious environment for investors. Overall, the stock is a value trap candidate unless operational efficiency improves.
HSAI presents a dichotomy between strong fundamental health and an aggressive valuation. The Piotroski F-Score of 6/9 indicates a stable financial condition, supported by an exceptionally low Debt/Equity ratio (0.09) and high liquidity (Current Ratio 3.73). However, the stock trades at a significant premium to its Graham Number ($9.07) and Intrinsic Value ($3.08), suggesting the market is pricing in substantial future growth. While revenue growth is robust at 39% YoY, the bearish technical trend and lukewarm insider sentiment offset the 'Strong Buy' analyst consensus.
Compare Another Pair
Related Comparisons
GEF vs HSAI: Head-to-Head Comparison
This page compares Greif, Inc. (GEF) and Hesai Group (HSAI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.